Related Interviews

Being More Selective and Focusing on Data in the Gene Therapy Space
April 05, 2019
Amusa, Gbola

A Big Year Ahead for Gene and Cell Therapy Companies
March 22, 2019
Prasad, Raju

Clinical Data and M&A Serve as Catalysts in 2019
March 22, 2019
Roy, Soumit

Using Convertibles for the Equity Upside and Downside Protection
October 19, 2018
Calamos Sr., John P.

Gene Therapy Companies with Better Clinical Data and Benefits Likely to Do Well
October 02, 2018
Yang, Difei

Relatively Healthy Valuations for Development-Stage Companies
October 02, 2018
Nierengarten, David

Data Consistency is Important When Investing in Gene Therapy
March 21, 2018
Chattopadhyay, Debjit

Gene Editing Companies Have Long-Term Potential to Be M&A Targets
March 16, 2018
Amusa, Gbola

Investing in Disruptive High-Growth Companies
April 08, 2016
Tubbs, Leslie

Stretched Valuations in Biotech Require Cautious Approach
December 15, 2014

Handpicked Stocks in Emerging Pharmaceuticals
November 24, 2014

Defensive Plays In The Defense Space - Michael F. Ciarmoli - Keybanc Capital Markets Inc.
November 14, 2011

Investing In Small- & Midcap Biotech Companies - Dr. Jason Kantor - Rbc Capital Markets
April 04, 2011

An Eye On Value & Long-term Growth In Health Services - Dr. Alastair Mackay - Garp Research & Securities
November 15, 2010

Post-crunch Trends In Biotechnology - Dr. Liana Moussatos - Wedbush Morgan Securities, Inc.
October 19, 2009

Roundtable Forum: Midwest Banks
June 15, 2009

"GROWTH AT A DISCOUNT" VALUE INVESTING - ADRIANA R. POSADA - AMERICAN BEACON ADVISORS, INC.
August 27, 2007

PULMONARY ARTERIAL HYPERTENSION: ANDREW FEIN - C.E. UNTERBERG, TOWBIN
July 03, 2006

INVESTING IN SUNBELT COMMUNITY BANKS: J.DEMBA / G.TENNER - SUNTRUST ROBINSON HUMPHREY
September 28, 2004

Martin Gerstel - Compugen Ltd (cgen)
May 03, 2004

Investment Opportunities In The Energy Supply Chain: J.smith - Gabelli Asset Management
September 01, 2003

Roundtable Forum: Transportation & Logistics
August 04, 2003

Joseph Mollica - Pharmacopeia Inc (pcop)
June 02, 2003

David Fried - Fried Asset Management Inc
December 16, 2002

Robert Ingram - Glaxosmithkline Plc (gsk)
November 01, 2002

Ron Davis - Security Associates International Inc (sai)
April 17, 2000